Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L FELDMAN

Showing results (1481-1490 of 1,491) with videos related to

Pageof 150
Sort By:
Blood|December 2, 2025
Gene expression profiling reveals two overarching types of ALCL with distinct targetable biology: an LLMPP studyAndrew L Feldman, Surendra Dasari, Lisa M Rimsza, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|November 13, 2025
The Neighborhoods Study: Examining the social exposome in Alzheimer's disease and related dementiasGrace C George, Sarah A Keller, Erin Abner, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|February 21, 2024
Presenilin-1 mutation position influences amyloidosis, small vessel disease, and dementia with disease stageNelly Joseph-Mathurin, Rebecca L Feldman, Ruijin Lu, et al.
JCO Precision Oncology|February 15, 2019
Molecular Modeling and Functional Analysis of Exome Sequencing-Derived Variants of Unknown Significance Identify a Novel, Constitutively Active FGFR2 Mutant in CholangiocarcinomaJan B Egan, David L Marks, Tara L Hogenson, et al.
Blood|June 2, 2022
The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory CommitteeElias Campo, Elaine S Jaffe, James R Cook, et al.
Blood|August 24, 2022
Genomic profiling for clinical decision making in lymphoid neoplasmsLaurence de Leval, Ash A Alizadeh, P Leif Bergsagel, et al.
Cancer Research|May 9, 2018
HLA Class I and II Diversity Contributes to the Etiologic Heterogeneity of Non-Hodgkin Lymphoma SubtypesSophia S Wang, Mary Carrington, Sonja I Berndt, et al.
Nature Communications|October 12, 2018
Two high-risk susceptibility loci at 6p25.3 and 14q32.13 for Waldenström macroglobulinemiaMary L McMaster, Sonja I Berndt, Jianqing Zhang, et al.
Journal of the National Cancer Institute. Monographs|September 1, 2014
Etiologic heterogeneity among non-Hodgkin lymphoma subtypes: the InterLymph Non-Hodgkin Lymphoma Subtypes ProjectLindsay M Morton, Susan L Slager, James R Cerhan, et al.
International Journal of Transgender Health|October 14, 2022
Standards of Care for the Health of Transgender and Gender Diverse People, Version 8E Coleman, A E Radix, W P Bouman, et al.
Pageof 150

Showing results (1481-1490 of 1,491) with videos related to

Sort By:
Pageof 150
Blood|December 2, 2025
Gene expression profiling reveals two overarching types of ALCL with distinct targetable biology: an LLMPP studyAndrew L Feldman, Surendra Dasari, Lisa M Rimsza, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|November 13, 2025
The Neighborhoods Study: Examining the social exposome in Alzheimer's disease and related dementiasGrace C George, Sarah A Keller, Erin Abner, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|February 21, 2024
Presenilin-1 mutation position influences amyloidosis, small vessel disease, and dementia with disease stageNelly Joseph-Mathurin, Rebecca L Feldman, Ruijin Lu, et al.
JCO Precision Oncology|February 15, 2019
Molecular Modeling and Functional Analysis of Exome Sequencing-Derived Variants of Unknown Significance Identify a Novel, Constitutively Active FGFR2 Mutant in CholangiocarcinomaJan B Egan, David L Marks, Tara L Hogenson, et al.
Blood|June 2, 2022
The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory CommitteeElias Campo, Elaine S Jaffe, James R Cook, et al.
Blood|August 24, 2022
Genomic profiling for clinical decision making in lymphoid neoplasmsLaurence de Leval, Ash A Alizadeh, P Leif Bergsagel, et al.
Cancer Research|May 9, 2018
HLA Class I and II Diversity Contributes to the Etiologic Heterogeneity of Non-Hodgkin Lymphoma SubtypesSophia S Wang, Mary Carrington, Sonja I Berndt, et al.
Nature Communications|October 12, 2018
Two high-risk susceptibility loci at 6p25.3 and 14q32.13 for Waldenström macroglobulinemiaMary L McMaster, Sonja I Berndt, Jianqing Zhang, et al.
Journal of the National Cancer Institute. Monographs|September 1, 2014
Etiologic heterogeneity among non-Hodgkin lymphoma subtypes: the InterLymph Non-Hodgkin Lymphoma Subtypes ProjectLindsay M Morton, Susan L Slager, James R Cerhan, et al.
International Journal of Transgender Health|October 14, 2022
Standards of Care for the Health of Transgender and Gender Diverse People, Version 8E Coleman, A E Radix, W P Bouman, et al.
Pageof 150